Carvedilol Tablet, Film Coated
Product Images NDC 67296-1899

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 67296-1899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-00)

Label for Carvedilol Tablets, USP 12.5 mg film-coated tablets. The label indicates 1000 tablets per container, prescription only. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. Storage instructions and warnings about seal integrity and moisture protection are also included.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-01)

This is a label for Carvedilol Tablets USP, 12.5 mg strength, in a package containing 100 film-coated tablets. The label includes storage instructions, a barcode, and manufacturing and distribution information. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited. It is marked Rx Only and shows the NDC number 72888-036-01.*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-30)

Label for Carvedilol Tablets USP 12.5 mg, containing 30 film-coated tablets. The label includes storage instructions, a barcode, and distributor and manufacturer details. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label also features the Advagen logo and states 'Rx Only.'*

FDA Label Image

Carvedilol Tablets Usp, 12.5 mg (NDC 72888-036-05)

Label for Carvedilol Tablets, USP 12.5 mg with 500 tablets per container. The label includes storage instructions, distributor Advagen Pharma Limited, and manufacturer Rubicon Research Private Limited. It states NDC 72888-036-05 and indicates Rx only. The label also cautions about seal integrity and moisture protection.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-00)

Label for Carvedilol Tablets, USP 25 mg film-coated tablets, in a 1000 tablets package. The label states storage instructions, seal integrity warning, and dispensing instructions. Distributed by Advagen Pharma Limited, USA, and manufactured by Rubicon Research Private Limited, India. Includes barcodes and the Advagen logo.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-01)

Carvedilol Tablets USP 25 mg film-coated oral tablets packaging label showing 100 tablets per container. Labeled for prescription use only, distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited, India. The label includes storage instructions, dosage advisory, barcodes, and company logos.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-30)

Label for Carvedilol Tablets USP 25 mg in a 30-tablet package. The film-coated tablets are prescription only. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. Label includes storage instructions, dosage note to see prescribing information, and barcode.*

FDA Label Image

Carvedilol Tablets Usp, 25 mg (NDC 72888-037-05)

Carvedilol Tablets, USP 25 mg film-coated oral tablets label, showing a carton panel with 500 tablets quantity. Distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. Contains handling instructions, dosage note, and storage conditions. NDC 72888-037-05 visible on label.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-00)

Carvedilol Tablets USP 3.125 mg label displaying 1000 tablets for prescription use. Distributed by Advagen Pharma Limited in Plainsboro, NJ, and manufactured by Rubicon Research Private Limited in India. The label includes storage instructions, dosage advisory, and barcode with NDC 72888-034-00. The Advagen logo is present at the bottom center.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-01)

Carvedilol Tablets, USP 3.125 mg film-coated tablets packaging label showing a quantity of 100 tablets. The label includes storage instructions, a barcode, NDC 72888-034-01, and details about distribution by Advagen Pharma Limited and manufacturing by Rubicon Research Private Limited. The label features dosage and cautionary text along with a designated overprinting area.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-30)

Label for Carvedilol Tablets, USP 3.125 mg, with 30 tablets per container. The label includes storage instructions to keep below 30ºC and protect from moisture. It notes the product is Rx only, distributed by Advagen Pharma Limited, and manufactured by Rubicon Research Private Limited, India. The label features a barcode and a warning not to accept if the seal under the cap is broken.*

FDA Label Image

Carvedilol Tablets Usp, 3.125 mg (NDC 72888-034-05)

This label is for Carvedilol Tablets, USP 3.125 mg, presented in a bottle containing 500 film-coated tablets. The label includes storage instructions (store below 30°C and protect from moisture) and cautions about the seal integrity. It lists Advagen Pharma Limited as distributor and Rubicon Research Private Limited as manufacturer.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-00)

Label for Carvedilol Tablets, USP 6.25 mg, film-coated oral tablets distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label shows a package size of 1000 tablets, includes storage instructions, dosage caution, and barcode details.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-01)

Label for Carvedilol Tablets, USP 6.25 mg, film-coated tablets, containing 100 tablets per container. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Private Limited. Instructions include storage below 30°C, protection from moisture, and warnings about the integrity of the seal. The label displays the NDC 72888-035-01 and has barcode and lot/revision information.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-30)

This is a packaging label for Carvedilol Tablets, USP with a strength of 6.25 mg, provided as 30 film-coated tablets. The label indicates the product is Rx only, distributed by Advagen Pharma Limited, and manufactured by Rubicon Research Private Limited. Storage instructions and warnings about the seal are included.*

FDA Label Image

Carvedilol Tablets Usp, 6.25 mg (NDC 72888-035-05)

Label for Carvedilol Tablets USP 6.25 mg, film-coated oral tablets. The label indicates a quantity of 500 tablets and is marked Rx Only. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, India. Storage instructions and warnings about the seal condition are included. Barcode and NDC 72888-035-05 are visible.*

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Tab Usp Figure1)

A line graph comparing mortality percentages over time in months between placebo and carvedilol groups. The x-axis represents months from 0 to 21, and the y-axis shows percent mortality from 0 to 30. The carvedilol group exhibits consistently lower mortality than the placebo group, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Tab Usp Figure2)

A forest plot showing hazard ratios with confidence intervals for different patient subgroups including men, women, age groups, race, diabetic status, ischemic status, heart rate, systolic blood pressure categories, and spironolactone use, along with an overall effect for all patients. The x-axis displays hazard ratios ranging from 0.0 to 2.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Tab Usp Figure3)

A line graph comparing percentage mortality over 24 months between Carvedilol and placebo groups. The y-axis shows % mortality up to 30%, and the x-axis shows time in months from 0 to 24. The lines indicate lower mortality with Carvedilol compared to placebo, with a statistical significance of P = 0.03.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Tab Usp Figure4)

A forest plot comparing hazard ratios for various subgroups including age, sex, treatment timing, prior beta-blocker use, Killip class, thrombolytic use, and other clinical characteristics. Each subgroup has hazard ratios with confidence intervals displayed, showing the relationship between variables and outcome hazards.*

FDA Label Image

Carvedilol Chemical Structure (Carvedilol Tab Usp Structure)

Chemical structure of Carvedilol displayed as a 2D molecular diagram showing its specific arrangement of atoms and bonds, including a carbazole moiety and phenyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.